The 3rd Bandung International Conference on Collaborative Health Research (BICCHR) 2020

Call for Papers

BICCHR is an annual scientific conference that brings together academicians, researchers, scientists, healthcare professionals, policymakers, healthcare providers, and pharmaceutical industries from Indonesia and other countries to present their latest research ideas, development, and applications in all areas of health research.  The 1st and 2nd BICCHR was previously held in 2017 and 2019 in Bandung, Indonesia.

Maintaining High-Quality Conference Standards and Publication Standards 

The conference is specially designed by the TIIKM Research and Development team together with a committee of international experts with the guidance of the Academic Governing Body of TIIKM conferences. The 3rd BICCHR 2020 is under the guidelines of the Committee on Publication Ethics (COPE).

Theme of the 3rd BICCHR 2020 Conference

Escalating Health Interventions for Mitigating the COVID-19 Pandemic

Since the World Health Organization (WHO) has upgraded the status of the novel coronavirus disease 2019 (COVID-19) outbreak from epidemic to pandemic on March 11, 2020, the threat of this disease has been a major public health concern all over the world. As a part of mitigation strategies during the COVID-19 pandemic, various health interventions have been recommended by the WHO to control infection spread and to reduce the illness attack rate. Multidisciplinary and collaborative researches are required to escalate the efforts for mitigating the COVID-19 pandemic.

We invite you to submit an abstract in the range of the following tracks but not limited to:


Conference Tracks

  • Medicine
  • Pharmacy
  • Dentistry
  • Nursing
  • Psychology
  • Public Health
  • Epidemiology
  • Health Policy
  • Health Economics
  • Behavioral and Social Health
  • Other disciplines

Abstract Submission and Deadlines

Please follow the abstract guidelines and send the abstract to . If you wish to be a presenter at the 3rd BICCHR 2020, you can register now.